Daniel E Gomez Selected Research

CMPacetylneuraminate monooxygenase (CMP-N-acetylneuraminate monooxygenase)

7/2012	Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides.
12/2009	Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel E Gomez Research Topics

Disease

40	Neoplasms (Cancer) 01/2022 - 01/2002
16	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2002
15	Carcinoma (Carcinomatosis) 04/2019 - 01/2002
14	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2002
10	Melanoma (Melanoma, Malignant) 01/2020 - 03/2002
6	Hemorrhage 01/2015 - 09/2002
5	Experimental Melanoma 07/2012 - 01/2003
4	Lung Neoplasms (Lung Cancer) 04/2012 - 12/2003
3	Carcinogenesis 01/2014 - 09/2004
2	Residual Neoplasm 09/2008 - 12/2006
2	Lymphatic Metastasis 11/2006 - 09/2002
1	Colorectal Neoplasms (Colorectal Cancer) 04/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Circulating Neoplastic Cells 01/2015
1	Glioma (Gliomas) 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012
1	Lewis Lung Carcinoma 01/2012
1	Adenocarcinoma 01/2012
1	Lung Diseases (Lung Disease) 01/2012
1	Lymphoma (Lymphomas) 03/2011
1	Ascites 12/2010
1	Colonic Neoplasms (Colon Cancer) 12/2010

Drug/Important Bio-Agent (IBA)

13	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 04/2019 - 09/2002
12	Vasopressins (Vasopressin)IBA 04/2019 - 09/2002
8	Peptides (Polypeptides)IBA 04/2019 - 09/2008
7	VaccinesIBA 07/2012 - 03/2002
6	GangliosidesIBA 07/2012 - 03/2002
6	EnzymesIBA 07/2012 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2003
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 01/2012
4	Hemostatics (Antihemorrhagics)IBA 01/2015 - 09/2002
4	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 09/2014 - 11/2006
3	CIGB-300IBA 06/2014 - 07/2011
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2013 - 01/2002
3	AntigensIBA 01/2012 - 03/2002
3	Monoclonal AntibodiesIBA 01/2012 - 03/2002
3	Tissue Inhibitor of Metalloproteinase-1IBA 11/2006 - 01/2003
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
2	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 03/2021 - 01/2012
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2020 - 01/2017
2	Biological ProductsIBA 01/2020 - 01/2012
2	Complement System Proteins (Complement)IBA 04/2019 - 01/2016
2	Arginine Vasopressin (Argipressin)IBA 04/2019 - 10/2008
2	Carmustine (FIVB)FDA Link 01/2016 - 09/2008
2	valyl(4)-glutaminyl(5)- desmopressinIBA 01/2016 - 12/2011
2	Cytostatic AgentsIBA 01/2015 - 01/2009
2	von Willebrand FactorIBA 01/2015 - 11/2006
2	Monomeric GTP-Binding ProteinsIBA 01/2014 - 01/2014
2	Anti-Idiotypic AntibodiesIBA 01/2013 - 12/2003
2	CMPacetylneuraminate monooxygenase (CMP-N-acetylneuraminate monooxygenase)IBA 07/2012 - 12/2009
2	Neoplasm Antigens (Tumor Antigens)IBA 07/2012 - 01/2012
2	Cancer VaccinesIBA 07/2012 - 03/2002
2	Messenger RNA (mRNA)IBA 07/2012 - 05/2008
2	racotumomabIBA 01/2012 - 01/2010
2	Peptide Hydrolases (Proteases)FDA Link 10/2006 - 01/2002
2	Matrix Metalloproteinases (MMPs)IBA 10/2006 - 01/2005
2	Metalloproteases (Metalloproteinases)IBA 10/2006 - 01/2005
2	beta-chimaerinIBA 01/2005 - 05/2003
1	SteroidsIBA 03/2021
1	Mutant Proteins (Protein, Mutant)IBA 01/2020
1	CateninsIBA 11/2016
1	Hormones (Hormone)IBA 01/2016
1	Cytotoxins (Cytolysins)IBA 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Keratin-19 (Keratin 19)IBA 01/2015
1	ElementsIBA 01/2015
1	Enoxaparin (Lovenox)FDA LinkGeneric 09/2014
1	AnticoagulantsIBA 09/2014
1	Tranexamic Acid (AMCA)FDA Link 09/2014
1	Epidermal Growth Factor (EGF)IBA 01/2014
1	ZINC69391IBA 01/2014
1	AngiostatinsIBA 11/2013
1	PlasminogenIBA 11/2013
1	CytidineIBA 07/2012
1	N-glycolylneuraminic acidIBA 07/2012
1	NucleophosminIBA 04/2012
1	aluminum sulfate (alum)IBA 01/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2012
1	Pemetrexed (MTA)FDA Link 01/2012
1	Complementary DNA (cDNA)IBA 01/2012
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2012
1	Estrogens (Estrogen)FDA Link 01/2012
1	Aluminum Hydroxide (Algeldrate)FDA Link 01/2012
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2012
1	Doxycycline (Periostat)FDA LinkGeneric 01/2012
1	Arachidonic Acid (Vitamin F)IBA 01/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2012
1	Glutamine (L-Glutamine)FDA Link 12/2011
1	Valine (L-Valine)FDA Link 12/2011
1	Cell-Penetrating PeptidesIBA 07/2011
1	Cyclic PeptidesIBA 07/2011
1	Atorvastatin (Lipitor)FDA Link 03/2011
1	MucinsIBA 12/2009

Therapy/Procedure

9	Therapeutics 03/2021 - 03/2002
5	Drug Therapy (Chemotherapy) 04/2019 - 09/2008
2	Operative Surgical Procedures 01/2015 - 12/2010
2	Intravenous Administration 11/2013 - 09/2008
1	Intravenous Infusions 01/2015
1	Immunotherapy 01/2010